Patents by Inventor Huai-Ping Ling

Huai-Ping Ling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7556938
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: October 31, 2000
    Date of Patent: July 7, 2009
    Assignees: Millennium Pharmaceuticals, Inc., Wyeth
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
  • Patent number: 7439029
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: October 21, 2008
    Assignees: Wyeth, Millennium Pharmaceuticals, Inc.
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
  • Publication number: 20070186296
    Abstract: TNFRSF19 nucleic acids and proteins, TNFRSF19 binding partners and modulators, and methods of using the same.
    Type: Application
    Filed: February 2, 2007
    Publication date: August 9, 2007
    Applicant: Wyeth
    Inventors: Ying Gao, Huai-Ping Ling, Andrew Wood, Kodangattil Sreekumar
  • Patent number: 7078481
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: September 27, 2000
    Date of Patent: July 18, 2006
    Assignees: Wyeth, Millennium Pharmaceuticals, Inc.
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
  • Patent number: 7041795
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: May 9, 2006
    Assignees: Millennium Pharmaceuticals, Inc, Wyeth
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wengian An
  • Publication number: 20050277761
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: April 8, 2002
    Publication date: December 15, 2005
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
  • Patent number: 6689581
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: July 9, 1999
    Date of Patent: February 10, 2004
    Assignees: Wyeth, Millennium Pharmaceuticals, Inc.
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
  • Publication number: 20030119102
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: March 25, 2002
    Publication date: June 26, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
  • Patent number: 6369197
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: April 9, 2002
    Assignees: Millennium Pharmaceuticals, Inc., American Home Products Corp.
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wengian An
  • Patent number: 6361971
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: March 26, 2002
    Assignees: Millennium Pharmaceuticals, Inc., American Home Products Corporation
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An